Kifua kikuu : Tofauti kati ya masahihisho
Content deleted Content added
Mstari 96:
Matibabu ya kifua kikuu ilipendekeza mpya-mwanzo ya mapafu, kama wa 2010, ni miezi sita ya macho ya antibiotiki zenye rifampicin, isoniazidi, pyrazinamide na ethambutol kwa miezi miwili ya kwanza, na tu rifampicin na isoniazidi [[pyrazinamide]], na [[ethambutol]]. kwa miezi minne iliyopita. <ref name=Lancet11/> Ambapo upinzani isoniazidi ni ya juu, ethambutol inaweza kuongezwa kwa miezi minne iliyopita kama mbadala.<ref name=Lancet11/>
===Matumizi ya Kawaida ugonjwa===
Kama kifua kikuu kurudia, kupima na kuamua ambayo antibiotiki ni nyeti ni muhimu kabla ya kuamua matibabu. <ref name=Lancet11/> Kama [[nyingi TB sugu]] (MDR-TB) ni wanaona, matibabu na antibiotiki angalau nne madhubuti kwa ajili ya miezi 18 hadi 24 ni ilipendekeza. <ref name=Lancet11/>
==Upinzani ya Dawa==
Upinzani Kanuni hutokea wakati mtu huwa wameambukizwa mnachuja sugu wa TB. Mtu aliye na TB kikamilifu wanahusika inaweza kuendeleza sekondari (alipewa) upinzani wakati wa tiba kwa sababu ya tiba za kutosha, si kuchukua regimen eda ipasavyo (ukosefu wa kufuata), au kwa kutumia chini quality dawa.<ref name=OBrien>{{cite journal |author=O'Brien R |title=Drug-resistant tuberculosis: etiology, management and prevention |journal=SeminRespir Infect |volume=9 |issue=2|pages=10412 |year=1994|pmid=7973169}}</ref> Sugu TB ni mbaya ya afya ya umma suala katika nchi nyingi zinazoendelea, kama tiba yake ni tena na inahitaji dawa ghali zaidi. MDR-TB hufafanuliwa kama upinzani kwa mbili ya ufanisi zaidi madawa ya TB ya mstari wa kwanza: rifampicin na isoniazidi. . [[Extensively drug-resistant tuberculosis| Sana sugu TB]] pia ni sugu kwa tatu au zaidi ya madarasa sita ya madawa ya mstari wa pili. .<ref name="MMWR2006">{{cite journal |title=Emergence of ''Mycobacterium tuberculosis'' with extensive resistance to second-line drugs—worldwide, 2000–2004 |journal=MMWR Morb Mortal Wkly Rep |volume=55 |issue=11 |pages=301–5 |year=2006|url=http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5511a2.htm|pmid = 16557213 |author=Centers for Disease Control and Prevention (CDC)}}</ref> [[Totally drug-resistant tuberculosis| Kabisa sugu TB]], ambayo kwa mara ya kwanza aliona katika 2003 nchini Italia, lakini si sana taarifa mpaka 2012, ni sugu kwa madawa yote kwa sasa kutumika. <ref> {{cite web|title=Totally Resistant TB: Earliest Cases in Italy |url=http://www.wired.com/wiredscience/2012/01/tdrfirstitaly/|author=Maryn McKenna date=12 January 2012|accessdate=12 January 2012|publisher=[[Wired(magazine)|Wired]]}}</ref>
| |||